Biologics Reached Record Share Of Novel Approvals In 2009
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The pharmaceutical industry’s strategy of looking to biologics as a source of innovation is clearly demonstrated in FDA’s novel approvals in 2009.